These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29402077)

  • 1. Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.
    Huard DJE; Crowley VM; Du Y; Cordova RA; Sun Z; Tomlin MO; Dickey CA; Koren J; Blair L; Fu H; Blagg BSJ; Lieberman RL
    ACS Chem Biol; 2018 Apr; 13(4):933-941. PubMed ID: 29402077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Grp94 components interact transiently with the myocilin olfactomedin domain in vitro to enhance or retard its amyloid aggregation.
    Huard DJE; Jonke AP; Torres MP; Lieberman RL
    Sci Rep; 2019 Sep; 9(1):12769. PubMed ID: 31484937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma.
    Stothert AR; Suntharalingam A; Huard DJ; Fontaine SN; Crowley VM; Mishra S; Blagg BS; Lieberman RL; Dickey CA
    Hum Mol Genet; 2014 Dec; 23(24):6470-80. PubMed ID: 25027323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.
    Suntharalingam A; Abisambra JF; O'Leary JC; Koren J; Zhang B; Joe MK; Blair LJ; Hill SE; Jinwal UK; Cockman M; Duerfeldt AS; Tomarev S; Blagg BS; Lieberman RL; Dickey CA
    J Biol Chem; 2012 Nov; 287(48):40661-9. PubMed ID: 23035116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.
    Burns JN; Orwig SD; Harris JL; Watkins JD; Vollrath D; Lieberman RL
    ACS Chem Biol; 2010 May; 5(5):477-87. PubMed ID: 20334347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligands for glaucoma-associated myocilin discovered by a generic binding assay.
    Orwig SD; Chi PV; Du Y; Hill SE; Cavitt MA; Suntharalingam A; Turnage KC; Dickey CA; France S; Fu H; Lieberman RL
    ACS Chem Biol; 2014 Feb; 9(2):517-25. PubMed ID: 24279319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion.
    Gobeil S; Letartre L; Raymond V
    Exp Eye Res; 2006 Jun; 82(6):1017-29. PubMed ID: 16466712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.
    Donegan RK; Hill SE; Turnage KC; Orwig SD; Lieberman RL
    J Biol Chem; 2012 Dec; 287(52):43370-7. PubMed ID: 23129764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.
    Burns JN; Turnage KC; Walker CA; Lieberman RL
    Biochemistry; 2011 Jul; 50(26):5824-33. PubMed ID: 21612213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.
    Crowley VM; Khandelwal A; Mishra S; Stothert AR; Huard DJ; Zhao J; Muth A; Duerfeldt AS; Kizziah JL; Lieberman RL; Dickey CA; Blagg BS
    J Med Chem; 2016 Apr; 59(7):3471-88. PubMed ID: 27003516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid fibril formation by the glaucoma-associated olfactomedin domain of myocilin.
    Orwig SD; Perry CW; Kim LY; Turnage KC; Zhang R; Vollrath D; Schmidt-Krey I; Lieberman RL
    J Mol Biol; 2012 Aug; 421(2-3):242-55. PubMed ID: 22197377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma.
    Stothert AR; Suntharalingam A; Tang X; Crowley VM; Mishra SJ; Webster JM; Nordhues BA; Huard DJE; Passaglia CL; Lieberman RL; Blagg BSJ; Blair LJ; Koren J; Dickey CA
    Sci Rep; 2017 Dec; 7(1):17951. PubMed ID: 29263415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.
    Patterson-Orazem AC; Hill SE; Wang Y; Dominic IM; Hall CK; Lieberman RL
    Biochemistry; 2019 Apr; 58(13):1718-1727. PubMed ID: 30802039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Insights into Myocilin and Its Glaucoma-Causing Misfolded Olfactomedin Domain Variants.
    Lieberman RL; Ma MT
    Acc Chem Res; 2021 May; 54(9):2205-2215. PubMed ID: 33847483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
    Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
    J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward development of a proteostasis drug for myocilin-associated glaucoma.
    Huard DJ; Lieberman RL
    Future Med Chem; 2018 Jun; 10(12):1391-1393. PubMed ID: 29788763
    [No Abstract]   [Full Text] [Related]  

  • 17. The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence.
    Hill SE; Donegan RK; Lieberman RL
    J Mol Biol; 2014 Feb; 426(4):921-35. PubMed ID: 24333014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable calcium-free myocilin olfactomedin domain variants reveal challenges in differentiating between benign and glaucoma-causing mutations.
    Hill SE; Kwon MS; Martin MD; Suntharalingam A; Hazel A; Dickey CA; Gumbart JC; Lieberman RL
    J Biol Chem; 2019 Aug; 294(34):12717-12728. PubMed ID: 31270212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
    Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
    ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimedin: a novel olfactomedin-related protein that interacts with myocilin.
    Torrado M; Trivedi R; Zinovieva R; Karavanova I; Tomarev SI
    Hum Mol Genet; 2002 May; 11(11):1291-301. PubMed ID: 12019210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.